quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:42:36·650d
NEWSRelease
Renalytix plc logo

HC Wainwright & Co. Reiterates Buy on Renalytix, Maintains $3 Price Target

RNLX· Renalytix plc
Health Care
Original source

Companies

  • RNLX
    Renalytix plc
    Health Care

Recent analyst ratings

  • Jan 18UpdateHC Wainwright & Co.$30.00
  • Jan 4UpdateBTIG$24.00
  • Oct 4UpdateGuggenheim$28.00
  • Jul 2UpdateBerenberg$38.00

Related

  • SEC559d
    SEC Form DEF 14A filed by Renalytix plc
  • PR562d
    Commencement of trading on OTCQB in the United States
  • 13D/G568d
    Amendment: SEC Form SC 13D/A filed by Renalytix plc
  • SEC569d
    SEC Form PRE 14A filed by Renalytix plc
  • SEC569d
    Renalytix plc filed SEC Form 8-K: Results of Operations and Financial Condition, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities
  • SEC570d
    SEC Form 10-K filed by Renalytix plc
  • SEC604d
    Renalytix plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC647d
    Renalytix plc filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022